✦ LIBER ✦

Time to recurrence of squamous cell carcinoma of the head and neck

✍ Scribed by Professor Philip M. Stell

Publisher: John Wiley and Sons
Year: 1991
Tongue: English
Weight: 403 KB
Volume: 13
Category: Article
ISSN: 1043-3074
DOI: 10.1002/hed.2880130403

No coin nor oath required. For personal study only.

✦ Synopsis

A personal series of 3,215 patients with proven squamous cell carcinoma of the mucosal surfaces of the upper aerodigestive tract is presented. Of these patients, 515 suffered a recurrence of their primary tumor after a course of radiotherapy. The time from the end of radiotherapy to diagnosis of a primary recurrence was not related to any known host factors, nor to tumor factors except site. However, it was the most significant predictor of survival, both from initial presentation and from the date of recurrence. The time to recurrence did not relate to the size of the tumor at recurrence, suggesting that large recurrences are multicentric. The time to recurrence also predicted response and survival of 67 patients with end-stage disease treated by chemotherapy. The response and survival were better in tumors with a time to recurrence longer than the median; the increased survival was not significant, but the increased response was.

📜 SIMILAR VOLUMES

Salvage of recurrent head and neck squam

Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery

✍ Ling Yuen Wong; William Ignace Wei; Lai Kun Lam; Anthony Po Wing Yuen 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

## Purpose: The efficacy of salvage treatment of recurrent head and neck squamous cell carcinomas (hnscc) after primary curative surgery was evaluated. ## Methods: The management outcome of 377 patients who had recurrent squamous cell carcinoma of oral cavity, oropharynx, hypopharynx, and larynx

Pain as sign of recurrent disease in hea

Pain as sign of recurrent disease in head and neck squamous cell carcinoma

✍ Miriam Smit; Alfonsus J. M. Balm; Frans J. M. Hilgers; I. Bing Tan 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 1 views

## Abstract ## Background The role of pain in head and neck cancer is seldom addressed. This retrospective study examined in a group of 190 curatively treated patients to what extent pain complaints should be considered to be the first sign of recurrent disease. ## Methods The research populatio

Utility of CT surveillance for primary s

Utility of CT surveillance for primary site recurrence of squamous cell carcinoma of the head and neck

✍ Brian P. Sullivan; Karen A. Parks; Nichole R. Dean; Eben L. Rosenthal; William R 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB 👁 1 views

## Abstract ## Background The literature directly comparing the utility of clinical examination (CE) to that of CT in detecting recurrence of squamous cell carcinoma (SCC) for primary site recurrences is lacking. ## Methods Patients who received both CT scans and CEs after primary treatment for

Vinblastine, bleomycin and cisplatin for

Vinblastine, bleomycin and cisplatin for recurrent or metastatic squamous cell carcinoma of the head and neck

✍ David J. Perry; Martin D. Weltz; Archie W. Brown Jr; Robert L. Henderson; Willia 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 315 KB 👁 3 views

Forty-two patients with recurrent or metastatic squamous cell carcinoma of the head and neck were treated with vinblastine, bleomycin, and cisplatin. All patients had received prior surgery, radiation or chemotherapy and all had measurable disease. Forty-five percent of the patients responded with a

Bone metastases from squamous cell carci

Bone metastases from squamous cell carcinoma of the head and neck

✍ Marc P. Pietropaoli; Timothy A. Damron; Andrei I. Vermont 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 265 KB 👁 2 views

Background and Objectives: Carcinoma of the head and neck is an uncommon primary source of bone metastases. The increasing duration of survival of these patients, however, increases the probability of late bone involvement. The objective was to identify the frequency, clinical presentation, and clin

Targeted therapies in squamous cell carc

Targeted therapies in squamous cell carcinoma of the head and neck

✍ Kathryn A. Gold; Ho-Young Lee; Edward S. Kim 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 3 views

## Abstract Head and neck cancer is a challenging disease that is expected to account for greater than 500,000 new cases worldwide in 2008. Toxicity has impeded advances in chemotherapy and radiation for head and neck cancer, and the prognosis for patients with recurrent and/or metastatic disease r